baber/WOPTO huggingface dataset:
Patent AU-2018211529-A1 (AU)
Title: N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxa zin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating autoimmune diseases
Inventor: DELHOMEL JEAN-FRANÇOIS
IPC: C07D241/52
Filed: 2018-01-29
Abstract: The present invention provides e.g. N-{[2-(piperidin-1-yl)phenyl] (phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating e.g. autoimmune diseases, autoimmune-related diseases, inflammatory diseases, metabolic diseases, fibrotic diseases or cholestatic diseases, such as e.g. arthitis and asthma.
Patent AU-2018223169-A1 (AU)
Title: Therapeutic device for intraoral use and method for operating such a therapeutic device
Inventor: BERK BIANCA
IPC: A61F5/56
Filed: 2018-02-26
Abstract: The invention relates to a therapeutic device for intraoral use for the treatment of teeth grinding and/or tongue thrusting and/or snoring, having: at least two fastening elements (10) for fixing the therapeutic device (1) in place on at least one tooth (4) of an upper jaw and/or lower jaw of a user; at least one sensor element (30) designed and configured to detect compressive loading events and/or sound events and/or vibration events in the oral cavity of the user; at least one stimulation element (50) for stimulating the user when a compressive loading event and/or a sound event and/or a vibration event occurs; and a control and/or regulation unit (40) for the controlled and/or regulated operation of the stimulation element (50) depending on the occurring compressive loading event and/or sound event and/or vibration event; and a power supply.
Patent AU-2018250616-A1 (AU)
Title: Pregelatinized starches having high process tolerance and methods for making and using them
Inventor: SMOOT JAMES THOMAS
IPC: C08B30/14
Filed: 2018-04-11
Abstract: The present disclosure relates to pregelatinized starches having a high degree of process tolerance, and methods for making and using them. In one aspect, the disclosure provides a pregelatinized starch having no more than 15 wt% solubles and a sedimentation volume in the range of 15 mL/g to 45 mL/g, the pregelatinized starch comprising starch granules, wherein at least 50% of the starch granules swell but do not substantially fragment when processed in 95 °C water, the pregelatinized starch being in a substantially planar form. In another aspect, the disclosure provides a pregelatinized, drum-dried starch having no more than 15 wt% solubles and a sedimentation voiume in the range of 15 mL/g to 45 mL/g, the pregelatinized starch comprising starch granules, wherein at least 50% of the starch granules swell but do not substantially fragment when processed in 95 °C water.
Patent AU-2018253025-A1 (AU)
Title: Optical detection of air bubbles in either saline or blood or a mixture of both
Inventor: KHAIR MOHAMMAD
IPC: G01N33/49
Filed: 2018-04-02
Abstract: Embodiments of the disclosure provide a system and method for detection of a transient air bubble in an arterial blood flow path during dialysis (e.g., hemodialysis). The system uses measurements from an optical sensor to remove one or more effects of common factors affecting the absorbance of the light incident on the arterial tubing. These factors include color of medium within the arterial tubing, tubing color, angle of illumination, and temperature of the optical detector. A variance of the measurements from the optical sensor are used to determine whether an air bubble is present.
Patent AU-2018285814-A1 (AU)
Title: A water purification apparatus and a method for controlling at least one fluid property in a water purification apparatus
Inventor: JANSSON OLOF
IPC: C02F1/44
Filed: 2018-06-13
Abstract: The present disclosure relates to a water purification apparatus that comprises a reverse osmosis device, RO-device, producing a purified water flow and to a corresponding method. The proposed method comprises detecting at least one fluid property of purified water in the purified water path and regulating a flow rate of water in the recirculation path to fulfil one or more predetermined criteria of the purified water in the purified water path, based on the at least one detected fluid property. The present disclosure also relates to a computer program and a computer program product implementing the method.
Patent AU-2018308379-A1 (AU)
Title: Antenna system with multiple synchronously movable feeds
Inventor: PATEL TRUSHAR
IPC: H01Q5/45
Filed: 2018-07-25
Abstract: The antenna system and the method receive signals having radio frequencies in a plurality of radio frequency bands. The antenna system includes a support assembly, a primary reflector that is coupled to the support assembly, a feed assembly that is movably coupled to the support assembly, and a first feed and a second feed fixedly coupled to the feed assembly. The first feed and the second feed are configured to communicate RF signals in a first frequency band and a second frequency band, respectively, of the plurality of frequency bands. The antenna system also includes a first actuator that is configured to move the feed assembly from a first feed assembly position, where the first feed is positioned along a first signal path with the primary reflector, to a second feed assembly position, where the second feed is positioned along a second signal path with the primary reflector.
Patent AU-2018326211-A1 (AU)
Title: Measuring and mixing devices
Inventor: MEISNER ROLAND
IPC: B05B7/24
Filed: 2018-08-15
Abstract: The invention relates to a measuring and mixing device comprising a cartridge holder (1) and a cartridge (2), a flat, at least form-fit connection being mounted between the cartridge and the holder. The invention also relates to a method for coating substrates with two or multi-component coating agents, in which the measuring and mixing device is used.
Patent AU-2018359492-A1 (AU)
Title: Adenovirus and uses thereof
Inventor: UIL TACO GILLES
IPC: A61K35/761
Filed: 2018-10-30
Abstract: Provided herein are adenoviral nucleic acid sequences and adenoviral vectors comprising said nucleic acid sequences. The provided adenoviral vectors can be used to induce a protective immune response in a subject.
Patent AU-2018382355-A1 (AU)
Title: Plant-protein based texturized oil-in-water emulsions
Inventor: SCHMITT CHRISTOPHE JOSEPH ETIENNE
IPC: A23D7/005
Filed: 2018-12-04
Abstract: The invention relates to a method of producing a plant- based oil-in-water emulsion comprising the steps of providing an ingredient composition which is free from dairy protein, said composition comprising 1.5 to 5 wt. %, preferably 2 to 5 wt. % proteins, wherein the protein consist of plant protein only, 0.5 to 10.5 wt%, preferably 1.5 to 7.5 wt% of oil, and having a pH of 5.3 - 6.7, preferably 5.6 - 6.6, optionally adding divalent cations to provide a concentration of 1 - 5 mM free divalent cations in the ingredient composition, optionally adding monovalent cations to provide a concentration of 1 - 20 mM free monovalent cations in the ingredient composition and homogenizing and subsequently heat treating the ingredient composition to a temperature of 80°- 100°C for a period of 0.5 - 15 min or an ultra high temperature (UHT) heat treatment above 135°C for 3 to 30 s to form agglomerated proteins comprising plant proteins and oil, and shearing the composition during or after the heat treatment to reduce the size of the agglomerated proteins, the agglomerates having a size of 5 to 50 microns as measured by D(4,3) mean diameter as measured by laser diffraction after the shearing. The invention also relates to a plant-based oil-in-water emulsion obtained by the method, and a use of the plant-based oil-in-water emulsion for the use in food and beverage products.
Patent AU-2019200825-A1 (AU)
Title: A positive airway pressure system for treatment of a sleeping disorder
Inventor: RAPOPORT DAVID M
IPC: A61B5/08
Filed: 2019-02-07
Abstract: Described are a positive airway pressure system and method for treatment of a sleeping disorder in a patient. The system includes a generator, a sensor and a processing arrangement. The generator supplies airflow and applies a pressure to an airway of a patient. The sensor measures data corresponding to patient's breathing patterns. The processing arrangement analyzes the breathing patterns to determine whether the breathing patterns are indicative of a change or transition between states of a patient. The processing arrangement adjusts the pressure based on the change or transition between states of the patient.
Patent AU-2019202631-A1 (AU)
Title: Toggling biometric authentication
Inventor: VO HOANG TRUNG
IPC: G06F21/32
Filed: 2019-04-16
Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for receiving user input indicating a first user selection of a first form of biometric authentication from a plurality of forms of biometric authentication, providing a first interface for display on a user device, the first interface corresponding to the first form, receiving first biometric data, the first biometric data being provided using the first interface, and selectively enabling communication between the user device and a back-end system based on the first biometric data. IL" co z
Patent AU-2019202955-A1 (AU)
Title: Integrating a blockchain ledger with an application external to the blockchain ledger
Inventor: HAIMES DAVID JOSEPH
IPC: G06Q30/06
Filed: 2019-04-26
Abstract: Integrating a blockchain ledger with an application external to the blockchain ledger is disclosed. A first method determines a state, to be written to a blockchain ledger, based on a contract transaction. A second method determines a state, to be written to the blockchain ledger, based on an adapter transaction. The first method includes an invocation of the second method. The second method verifies whether the adapter transaction includes a particular set of information associated with a particular application. If the adapter transaction includes the particular set of information, then both the contract transaction and the adapter transaction are committed to the blockchain ledger. If the adapter transaction does not include the particular set of information, then neither the contract transaction nor the adapter transaction are committed to the blockchain ledger. The state determined based on the adapter transaction is used to update the particular application. System Nodes 105a Node Node 104d Application 104a 110a Node 104c Application Client ---- Side 102 - -Adapter Endorsing Nodes' 108 Node 105bApplication 104b Node 110b 104e Ordering Service Fig. 1A
Patent AU-2019203480-A1 (AU)
Title: Delamination container
Inventor: TARUNO SHINSUKE
IPC: B65D1/02
Filed: 2019-05-17
Abstract: A delaminatable container excellent in productivity is provided. According to the first aspect of the present invention, a delaminatable container, comprising: a container body having an outer shell and an inner bag, the inner bag delaminating from the outer shell and being shrunk with a decrease in contents, wherein the container body includes a bottom seal protrusion protruding from a bottom surface of a storage portion to store the contents, and the bottom seal protrusion is a sealing portion of, in blow molding using a cylindrical laminated parison provided with an outer layer constituting the outer shell and an inner layer constituting the inner bag, the laminated parison and is bent. [Selected Drawing] Fig. 1 b9 Fig.1(a) 7b 7a Fig.1(b) 7 7b Fig.1(c) 29a 29 7a 29c y 15 FR 29b w
Patent AU-2019206509-A1 (AU)
Title: Real-time remote control of vehicles with high redundancy
Inventor: HAN XIAOLING
IPC: H04W12/06
Filed: 2019-01-09
Abstract: Described are devices, systems and methods for real-time remote control of vehicles with high redundancy. In some embodiments, two copies of at least one control command are received using two different wireless communication protocols, and are compared. The at least one control command is executed when the two copies are in agreement, but is rejected when the two copies differ. In other embodiments, additional wireless communication protocols may exist to provide a redundant mode of communication when one of the two different wireless communication protocols are unavailable. In yet other embodiments, redundant GPS units may be used to determine availability of any of the communication protocols, and relevant control commands may be downloaded in advance to circumvent the lack of coverage.
Patent AU-2019214168-A1 (AU)
Title: Crystal form of small molecule immune compound, preparation method therefor and pharmaceutical composition containing same
Inventor: TANG TIAN
IPC: A61K31/496
Filed: 2019-01-31
Abstract: Provided in the present invention are a crystal form of a small molecule immune compound, a preparation method therefor and a pharmaceutical composition containing the same; the compound is (3Z,6Z)-3-[((E)-3-(5-tert-butyl)-1H-imidazolyl-4-yl)methylene]-6-((E)-3- (3-fluorophenyl)-2-propenylene)piperazine-2,5-dione; the crystal form thereof has stable morphology, good chemical stability, high temperature resistance, and is used for treating hyperproliferative diseases. The structural formula of the compound is as shown in formula (I).
Patent AU-2019222896-A1 (AU)
Title: System and method for wagering in a financial market environment
Inventor: RICHES GUY IAIN OLIVER
IPC: G06Q50/00
Filed: 2019-08-29
Abstract: SYSTEM AND METHOD FOR WAGERING IN A FINANCIAL MARKET ENVIRONMENT A method for providing a wager in a financial market environment is provided that includes presenting an opportunity to make a wager that is based on a moving 5 market line associated with a financial market. An end user is given an opportunity to bet on whether a financial market value will be above or below the moving market line at a designated time. The wager may be accepted from the end user. The wager may be monitored LO in order to determine whether the financial market value was above or below the moving market line at the designated time. WO 2005/088510 PCT/US2005/007219 USER INTERFACE 1 END USER INTERNET H - 20 12\,WRLS COMMUNICATIONS END USER - E--MWNRELES NETWORK 5 ELEMET 2250 2 END USER - ADMINISTRATOR CASINO 40 MODULE FACILITY 24 12 D CENTRAL CONTROLLER END USER - TELEVISION PROCESSOR MEMORY 12 28ELEMENT END USER BROKER 42 44 12 BR K 30 - I -- 0 FINANCIAL MARKET DATA ELEMENT 60 42 CENTRAL CONTROLLER 44 PROCESSOR MEMORY ELEMENT END-USER ODDS- PROFILES ODDS- / DETERMINATION 92 MODULE FINANCIAL 0 WO 2005/088510 PCT/US2005/007219 70 2/3 FIG. 2 ILadbrokes.com-Microsoft Internet Explorer 11xi file Edit View Go Tools .Help <j Back (> I(a earch favorite N Jiedia Address http://qa.cantorindex.co.uk/ldbrokesFO/FPrototype.cfn v eGo Links Instant Tax-Free tLOG INOPEN .com Web' BetnfoICON I DI( the WbsFavorite Bookmaker OGREYHOUNDS[(LTTO/POOLS' MOKER B Change language Beft Shor ut >> ©RST Check out All the Financial Market Prices... ? BANKING BET SETTLEMENT DAILY FTSE OFFICAL ARKET CLOSE 27/11/2003 Q CONTACT US £ REWARDS Ftse BET 74a Dow Jones 72 5/1 NASDAQ HIGHER CBOT HIGH LINE 4404 LME 74b LOWER 78a ASX 76a BET 1/12 BET 10/11 BET EVENS HIGHER HIGHER BALLS I>_A z 4361 Be a winner CURRENT MARKET 4354 4348 every minute LOWER 80a LOWER with Balls 810/11 BET EVENS CASINO b 76b BET 1/12 BET NEWHIGHER 78b Rio Bay LOW LINE 4306 ONE ACCOUNT b 5/1 Three ys BET 8Ob to bet Done, IOOOEmt
Patent AU-2019226342-A1 (AU)
Title: 2,4-diaminoquinazoline derivatives and medical uses thereof
Inventor: MC GOWAN DAVID CRAIG
IPC: A61P35/00
Filed: 2019-02-28
Abstract: This application relates to quinazoline derivatives of formula (I), pharmaceutical compositions comprising the compounds of formula (I), and the use of the compounds of formula (I) in the treatment or prevention of a viral infection, of a virus-induced disease, of cancer or of an allergy. In formula (I), R
Patent AU-2019230301-A1 (AU)
Title: Method for Manufacturing Concentrator Photovoltaic Module, and Transport Jig
Inventor: KOIKE YUKIO
IPC: H01L31/18
Filed: 2019-02-21
Abstract: Provided is a method for manufacturing a concentrator photovoltaic module which is provided with a plurality of power generation elements to which solar light is converged by a plurality of converging lenses and a chassis for housing the plurality of power generation elements, wherein the chassis is provided with a resin frame and a metal bottom plate sealing the bottom side opening of the frame and having an inside surface on which the plurality of power generation elements are disposed. The method includes: a first step of obtaining the chassis by attaching the peripheral edge of the inside surface of the bottom plate to the bottom end surface of the frame and fixing the bottom plate to the frame; and a second step of fixing the chassis to a carrier jig for carrying the chassis while being laid down horizontally. The carrier jig is provided with a support portion formed corresponding to the bottom end surface of the frame and supporting the chassis from below. In the second step, the chassis is fixed to the carrier jig while the support portion and the peripheral edge of the outside surface of the bottom plate are being attached to each other.
Patent AU-2019233183-A1 (AU)
Title: Phthalazine isoxazole alkoxy derivatives, preparation method thereof, pharmaceutical composition and use thereof
Inventor: WANG FEI
IPC: A61K31/502
Filed: 2019-03-12
Abstract: The present invention discloses phthalazine isoxazole alkoxy derivatives, a preparation method thereof, a pharmaceutical composition, and a use thereof. The present invention provides a compound represented by Formula I, cis-trans isomers thereof, enantiomers thereof, diastereoisomers thereof, racemates thereof, solvates thereof, hydrates thereof, and pharmaceutically acceptable salts or prodrugs thereof. The compound has an excellent inverse agonist effect with respect to α5-GABA
Patent AU-2019252262-A1 (AU)
Title: Human neuregulin-1 (NRG-1) recombinant fusion protein compositions and methods of use thereof
Inventor: LI JOHN
IPC: A61P9/00
Filed: 2019-04-11
Abstract: The present invention relates to a recombinant fusion protein comprising a fragment of the cardioprotective protein neuregulin-1 (NRG-1) fused to a monoclonal antibody (mAb) backbone and to a method of treating a disease or condition in a subject in need thereof comprising administering a therapeutically effective amount of the recombinant fusion protein or the pharmaceutical composition comprising the recombinant fusion protein disclosed herein.
Patent AU-2019254740-A1 (AU)
Title: Felling unit and method of harvesting small-dimensioned wood
Inventor: KARVANEN JANI
IPC: A01G23/089
Filed: 2019-04-16
Abstract: A felling unit and a method of harvesting small-dimensioned wood in a forest. A felling unit (5) comprises a cutting device (7) with two disc blades (19a, 19b) and a cutting gap (23) between them for cutting small-dimensioned trees. The cut small- dimensioned trunks are transferred from the cutting gap to a temporary storage space (9) by means of a transfer device (8) comprising two transfer shafts (18a, 18b) with a transfer gap (24) between them. The disc blades and the transfer shafts are both rotated in opposite directions relative to each other, i.e. towards the cutting gap and the feeding gap.
Patent AU-2019264622-A1 (AU)
Title: Corrosion-free dowel
Inventor: MASON GREG STEPHEN
IPC: E04G21/18
Filed: 2019-11-14
Abstract: C:\Interwovn\NRPortbl\DCC\TXB\19537740 _.docx-4/l/2019 A dowel for controlling relative level between adjacent panels, wherein the dowel is formed of corrosion-free material so as to avoid corrosion of the dowel. A concrete footpath formwork system including a dowel for transferring load between adjacent concrete panels, wherein the dowel is formed of corrosion-free material so as to avoid corrosion of the dowel. 8 20n 680 4 m 4 Al t, A
Patent AU-2019284091-A1 (AU)
Title: Decorative coating compositions
Inventor: PEREZ HECTOR ANTONIO
IPC: C09D7/61
Filed: 2019-12-24
Abstract: Abstract A coating composition includes water, a plurality of flakes having a maximum dimension less than 0.05 inches, a plurality of inorganic fibers, a thixotropic suspending agent that is insoluble in water, and a resin. Decorative coating on a concrete substrate is also provided.
Patent AU-2019284117-A1 (AU)
Title: Expandable stent delivery apparatus to cover an access site
Inventor: MCWEENEY JOHN O
IPC: A61F2/966
Filed: 2019-12-27
Abstract: EXPANDABLE STENT DELIVERY APPARATUS TO COVER AN 
ACCESS SITE 
ABSTRACT 
Methods, apparatuses and systems are described for expandable stent delivery apparatus to cover 
an access site. The method may include delivering the stent (170-b) through an access site and 
deploying a distal portion (235) of the stent (170-b) from within an outer sheath (105). In some 
cases, the method may further include pushing a proximal portion (230) of the stent (170-b) from 
the outer sheath (105) such that upon fully exiting the outer sheath (105), the proximal portion 
(230) extends proximally to at least partially cover the access site with the stent (170-b). The 
system (800) for delivering the stent into the body lumen may include a stent (870), a stent 
delivery apparatus, and an outer sheath (805). The system (800) may further include an internal 
pusher (830) configured to push a proximal portion (835) of the stent (870) from the outer sheath 
(805) and axially compress the stent (870) such that upon fully exiting the outer sheath (805), the 
proximal portion (835) extends proximally to cover the access site.
7/38 
245 180 
-'235 
170-a 
175 
210 
150 230 215 
205 
105 
240 
125 
165 
FIG. 2F 200
Patent AU-2019299836-A1 (AU)
Title: Improvements in immunogenic conjugates
Inventor: FAIRMAN JEFFERY
IPC: A61P37/00
Filed: 2019-07-01
Abstract: The present application discloses various improvements concerning immunogenic conjugates which comprise a carrier polypeptide and a saccharide antigen, wherein the saccharide antigen is covalently bonded to the carrier polypeptide via a non-natural amino acid residue therein.
Patent AU-2019301204-A1 (AU)
Title: Antibody molecules that bind PD-L1 and CD137
Inventor: LAKINS MATTHEW
IPC: A61P35/00
Filed: 2019-07-12
Abstract: The present application relates to antibody molecules that bind both PD-L1 and CD 137 and are able to induce agonism of CD137. The antibody molecules comprise a CDR-based binding site for PD-L1, and a CD137 antigen-binding site that is located in a constant domain of the antibody molecule. The antibody molecules of the invention find application, for example, in the treatment of diseases, such as cancer.
Patent AU-2019305075-A1 (AU)
Title: Nutritional compositions for enhancement of muscle performance
Inventor: SYED EZIAH
IPC: A61K31/4172
Filed: 2019-07-19
Abstract: Compositions comprising a plurality of particular essential amino acids, and methods of enhancing muscle performance by administering such compositions are provided herein.
Patent AU-2019313996-A1 (AU)
Title: Intranasal vaccine that induces cellular immunity
Inventor: YUKI YOSHIKAZU
IPC: A61K9/06
Filed: 2019-08-02
Abstract: The present invention provides a nanogel intranasal vaccine that induces cellular immunity. Specifically, the present invention relates to a vaccine formulation that comprises a complex of a nanogel, a vaccine antigen, and an adjuvant. The vaccine formulation can efficiently induce cellular immunity and also can induce a systemic and mucosal immune response.
Patent AU-2019316247-A1 (AU)
Title: Vehicle towing device
Inventor: MASCIALINO GIANPIETRO
IPC: B60D1/28
Filed: 2019-07-22
Abstract: A vehicle towing device, comprising a coupling assembly (2) removably engageable to a crossbeam (3) carried at the rear by a vehicle, and at least one sensor (S1, S2) comprising a first portion (P1) rigidly engageable with respect to the crossbeam (3) and a second portion (P2) rigidly carried by the coupling assembly (2). The sensor (S1, S2) is switchable between a first and a second operating condition to emit a warning signal following a relative displacement between the first portion (P1) and the second portion (P2). A signaling device operatively connected to said sensor (S1, S2) to emit an alarm signal in response to said warning signal.